DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance.

If a decreasing trend in the cell viability of each species emerged already at 6 h of treatment, with a decrease compared to the control condition ranging from −12% to −17.16% after Cisplatin treatment and from −23.27% to −28.31% after the treatment with the fourth‐generation prodrug in the different lines, statistically significant results could be appreciated at 48 h of acute treatment.

also in 47,180 other papers